Miinalainen IJ: Difference between revisions

From Bioblast
No edit summary
No edit summary
Line 2: Line 2:
|lastname=Miinalainen
|lastname=Miinalainen
|firstname=Ilkka
|firstname=Ilkka
|address=NICB
|title=Ph.D.
|institution=Biocenter Oulu Electron Microscopy Core Facility
University of Oulu


Centre for Bioanalytical Sciences (CBAS)


Dublin City University
|address=Aapistie 5A,
Β 
|area code=90220
Glasnevin, Dublin 9, Ireland
|city=Oulu
|country=Finland
|weblink=www. oulu.fi/biocenter/em
}}
}}
{{Labelingperson}}
{{Labelingperson}}

Revision as of 14:10, 20 June 2013

Name Miinalainen Ilkka, Ph.D.
Institution Biocenter Oulu Electron Microscopy Core Facility

University of Oulu

Address Aapistie 5A,, 90220
City Oulu
State/Province
Country Finland
Email [email protected]
Weblink www. oulu.fi/biocenter/em
O2k-Network Lab IE Dublin Miinalainen I


Labels:



Publications

 PublishedReference
Raesaenen 2016 Proc Natl Acad Sci U S A2016RΓ€sΓ€nen M, Degerman J, Nissinen TA, Miinalainen I, KerkelΓ€ R, Siltanen A, Backman JT, Mervaala E, Hulmi JJ, KivelΓ€ R, Alitalo K (2016) VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection. Proc Natl Acad Sci U S A 113:13144-49.

Abstracts

Add abstract

Cookies help us deliver our services. By using our services, you agree to our use of cookies.